You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創美藥業(02289.HK)建議委任張寒孜為執行董事
格隆匯 06-17 23:02

格隆匯6月17日丨創美藥業(02289.HK)公吿,姚創龍先生,作為公司的控股股東已向公司呈交關於委任張寒孜女士為執行董事的普通決議案。建議委任張女士為執行董事須獲得公司股東於2022年7月7日舉行的公司2022年第二次臨時股東大會以普通決議案的方式通過,如獲通過,其任命自該臨時股東大會同日生效,直至第三屆董事會任期屆滿為止。

江西江中醫藥商業運營有限責任公司,作為公司的主要股東已向公司呈交關於委任付徵女士為非執行董事的普通決議案。建議委任付女士為非執行董事須獲得股東於臨時股東大會以普通決議案的方式通過,如獲通過,其任命自該臨時股東大會同日生效,直至第三屆董事會任期屆滿為止。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account